4-cyclopropyl-N-[(S)-[7-[(1S)-1-[[2-(3,3-difluorocyclobutyl)acetyl]amino]butoxy]imidazo[1,2-b]pyridazin-2-yl]-(4,4-difluorocyclohexyl)methyl]-1,2,5-oxadiazole-3-carboxamide

C29H35F4N7O4 — CID 168861739

IUPAC4-cyclopropyl-N-[(S)-[7-[(1S)-1-[[2-(3,3-difluorocyclobutyl)acetyl]amino]butoxy]imidazo[1,2-b]pyridazin-2-yl]-(4,4-difluorocyclohexyl)methyl]-1,2,5-oxadiazole-3-carboxamide
SMILESCCC[C@@H](NC(=O)CC1CC(F)(F)C1)Oc1cnn2cc([C@@H](NC(=O)c3nonc3C3CC3)C3CCC(F)(F)CC3)nc2c1
InChIInChI=1S/C29H35F4N7O4/c1-2-3-23(36-22(41)10-16-12-29(32,33)13-16)43-19-11-21-35-20(15-40(21)34-14-19)24(18-6-8-28(30,31)9-7-18)37-27(42)26-25(17-4-5-17)38-44-39-26/h11,14-18,23-24H,2-10,12-13H2,1H3,(H,36,41)(H,37,42)/t23-,24-/m0/s1
InChIKeyZZQQVMTXLFDZLY-ZEQRLZLVSA-N
MW621.64 g/mol
LogP5.34
Rot. Bonds12

About 4-cyclopropyl-N-[(S)-[7-[(1S)-1-[[2-(3,3-difluorocyclobutyl)acetyl]amino]butoxy]imidazo[1,2-b]pyridazin-2-yl]-(4,4-difluorocyclohexyl)methyl]-1,2,5-oxadiazole-3-carboxamide

4-cyclopropyl-N-[(S)-[7-[(1S)-1-[[2-(3,3-difluorocyclobutyl)acetyl]amino]butoxy]imidazo[1,2-b]pyridazin-2-yl]-(4,4-difluorocyclohexyl)methyl]-1,2,5-oxadiazole-3-carboxamide (PubChem CID 168861739) has the molecular formula C29H35F4N7O4 and a molecular weight of 621.64 g/mol. Its IUPAC name is 4-cyclopropyl-N-[(S)-[7-[(1S)-1-[[2-(3,3-difluorocyclobutyl)acetyl]amino]butoxy]imidazo[1,2-b]pyridazin-2-yl]-(4,4-difluorocyclohexyl)methyl]-1,2,5-oxadiazole-3-carboxamide.

Molecular Properties

Compound Name4-cyclopropyl-N-[(S)-[7-[(1S)-1-[[2-(3,3-difluorocyclobutyl)acetyl]amino]butoxy]imidazo[1,2-b]pyridazin-2-yl]-(4,4-difluorocyclohexyl)methyl]-1,2,5-oxadiazole-3-carboxamide
PubChem CID168861739
Molecular FormulaC29H35F4N7O4
Molecular Weight621.64 g/mol
Exact Mass621.27
IUPAC Name4-cyclopropyl-N-[(S)-[7-[(1S)-1-[[2-(3,3-difluorocyclobutyl)acetyl]amino]butoxy]imidazo[1,2-b]pyridazin-2-yl]-(4,4-difluorocyclohexyl)methyl]-1,2,5-oxadiazole-3-carboxamide
SMILESCCC[C@@H](NC(=O)CC1CC(F)(F)C1)Oc1cnn2cc([C@@H](NC(=O)c3nonc3C3CC3)C3CCC(F)(F)CC3)nc2c1
InChIInChI=1S/C29H35F4N7O4/c1-2-3-23(36-22(41)10-16-12-29(32,33)13-16)43-19-11-21-35-20(15-40(21)34-14-19)24(18-6-8-28(30,31)9-7-18)37-27(42)26-25(17-4-5-17)38-44-39-26/h11,14-18,23-24H,2-10,12-13H2,1H3,(H,36,41)(H,37,42)/t23-,24-/m0/s1
InChIKeyZZQQVMTXLFDZLY-ZEQRLZLVSA-N
XLogP5.34
TPSA136.54 Ų
H-Bond Donors2
H-Bond Acceptors9
Rotatable Bonds12
Heavy Atoms44
Complexity

Lipinski Rule of Five

2 violations

RuleValue
MW ≤ 500621.64
LogP ≤ 55.34
H-Bond Donors ≤ 52
H-Bond Acceptors ≤ 109

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'het-C-het_not_in_ring', 'substructure': 'N/A'}

Analyze 4-cyclopropyl-N-[(S)-[7-[(1S)-1-[[2-(3,3-difluorocyclobutyl)acetyl]amino]butoxy]imidazo[1,2-b]pyridazin-2-yl]-(4,4-difluorocyclohexyl)methyl]-1,2,5-oxadiazole-3-carboxamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of 4-cyclopropyl-N-[(S)-[7-[(1S)-1-[[2-(3,3-difluorocyclobutyl)acetyl]amino]butoxy]imidazo[1,2-b]pyridazin-2-yl]-(4,4-difluorocyclohexyl)methyl]-1,2,5-oxadiazole-3-carboxamide?
The IUPAC name of 4-cyclopropyl-N-[(S)-[7-[(1S)-1-[[2-(3,3-difluorocyclobutyl)acetyl]amino]butoxy]imidazo[1,2-b]pyridazin-2-yl]-(4,4-difluorocyclohexyl)methyl]-1,2,5-oxadiazole-3-carboxamide (CID 168861739) is 4-cyclopropyl-N-[(S)-[7-[(1S)-1-[[2-(3,3-difluorocyclobutyl)acetyl]amino]butoxy]imidazo[1,2-b]pyridazin-2-yl]-(4,4-difluorocyclohexyl)methyl]-1,2,5-oxadiazole-3-carboxamide.
What is the SMILES notation for 4-cyclopropyl-N-[(S)-[7-[(1S)-1-[[2-(3,3-difluorocyclobutyl)acetyl]amino]butoxy]imidazo[1,2-b]pyridazin-2-yl]-(4,4-difluorocyclohexyl)methyl]-1,2,5-oxadiazole-3-carboxamide?
The canonical SMILES for 4-cyclopropyl-N-[(S)-[7-[(1S)-1-[[2-(3,3-difluorocyclobutyl)acetyl]amino]butoxy]imidazo[1,2-b]pyridazin-2-yl]-(4,4-difluorocyclohexyl)methyl]-1,2,5-oxadiazole-3-carboxamide is CCC[C@@H](NC(=O)CC1CC(F)(F)C1)Oc1cnn2cc([C@@H](NC(=O)c3nonc3C3CC3)C3CCC(F)(F)CC3)nc2c1.
What is the InChIKey of 4-cyclopropyl-N-[(S)-[7-[(1S)-1-[[2-(3,3-difluorocyclobutyl)acetyl]amino]butoxy]imidazo[1,2-b]pyridazin-2-yl]-(4,4-difluorocyclohexyl)methyl]-1,2,5-oxadiazole-3-carboxamide?
The InChIKey is ZZQQVMTXLFDZLY-ZEQRLZLVSA-N. The full InChI is InChI=1S/C29H35F4N7O4/c1-2-3-23(36-22(41)10-16-12-29(32,33)13-16)43-19-11-21-35-20(15-40(21)34-14-19)24(18-6-8-28(30,31)9-7-18)37-27(42)26-25(17-4-5-17)38-44-39-26/h11,14-18,23-24H,2-10,12-13H2,1H3,(H,36,41)(H,37,42)/t23-,24-/m0/s1.
What are the key properties of 4-cyclopropyl-N-[(S)-[7-[(1S)-1-[[2-(3,3-difluorocyclobutyl)acetyl]amino]butoxy]imidazo[1,2-b]pyridazin-2-yl]-(4,4-difluorocyclohexyl)methyl]-1,2,5-oxadiazole-3-carboxamide?
4-cyclopropyl-N-[(S)-[7-[(1S)-1-[[2-(3,3-difluorocyclobutyl)acetyl]amino]butoxy]imidazo[1,2-b]pyridazin-2-yl]-(4,4-difluorocyclohexyl)methyl]-1,2,5-oxadiazole-3-carboxamide has a molecular weight of 621.64 g/mol, XLogP of 5.34, 12 rotatable bonds, 2 hydrogen bond donors, and 9 hydrogen bond acceptors.
Where does this data come from?
All data for 4-cyclopropyl-N-[(S)-[7-[(1S)-1-[[2-(3,3-difluorocyclobutyl)acetyl]amino]butoxy]imidazo[1,2-b]pyridazin-2-yl]-(4,4-difluorocyclohexyl)methyl]-1,2,5-oxadiazole-3-carboxamide is sourced from PubChem (CID 168861739), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).